DUEARITY AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.38 SEK | -0.13% |
|
-2.44% | -82.88% |
| Mar. 11 | Duearity Unit Signs US Distribution Deal With Westone Laboratories | MT |
| Mar. 10 | Duearity Americas Inc Enters into an Agreement with Westone Laboratories | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 168.9 | 110.9 | 53.92 |
| Enterprise Value (EV) 1 | 156.3 | 105.3 | 64.16 |
| P/E ratio | -13.3 x | -5.33 x | -1.57 x |
| Yield | - | - | - |
| Capitalization / Revenue | 968 x | - | 32.6 x |
| EV / Revenue | 896 x | - | 38.8 x |
| EV / EBITDA | - | -5,540,487 x | -2,589,121 x |
| EV / FCF | -18,800,994 x | -7,442,770 x | -2,706,911 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 21.6 x | 18.3 x | -22.6 x |
| Nbr of stocks (in thousands) | 9,534 | 15,976 | 24,290 |
| Reference price 2 | 17.72 | 6.940 | 2.220 |
| Announcement Date | 3/14/22 | 3/14/23 | 4/11/24 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 0.000624 | 0.1745 | - | 1.654 |
| EBITDA | - | - | -19.01 | -24.78 |
| EBIT 1 | -2.271 | -15.36 | -19.17 | -25.76 |
| Operating Margin | -364,004.49% | -8,802.97% | - | -1,557.62% |
| Earnings before Tax (EBT) 1 | -2.271 | -15.44 | -19.24 | -26.19 |
| Net income 1 | -2.271 | -15.44 | -19.24 | -26.19 |
| Net margin | -364,004.49% | -8,848.56% | - | -1,583.43% |
| EPS 2 | -2.280 | -1.336 | -1.303 | -1.414 |
| Free Cash Flow | - | -8.314 | -14.15 | -23.7 |
| FCF margin | - | -4,765.08% | - | -1,432.94% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/14/22 | 3/14/22 | 3/14/23 | 4/11/24 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | 10.2 |
| Net Cash position 1 | 4.04 | 12.6 | 5.53 | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.4129 x |
| Free Cash Flow | - | -8.31 | -14.2 | -23.7 |
| ROE (net income / shareholders' equity) | - | -208% | -225% | -1,424% |
| ROA (Net income/ Total Assets) | - | -93.8% | -85.1% | -118% |
| Assets 1 | - | 16.46 | 22.6 | 22.12 |
| Book Value Per Share 2 | 0.2800 | 0.8200 | 0.3800 | -0.1000 |
| Cash Flow per Share 2 | 0.3000 | 1.050 | 0.4200 | 0.0100 |
| Capex | - | 0.62 | 1.02 | 1.87 |
| Capex / Sales | - | 353.05% | - | 113.3% |
| Announcement Date | 3/14/22 | 3/14/22 | 3/14/23 | 4/11/24 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -82.88% | 926K | |
| +9.80% | 32.94B | |
| +24.92% | 7.83B | |
| +36.69% | 4.26B | |
| -28.70% | 2.74B | |
| -20.62% | 1.39B | |
| -28.50% | 1.27B | |
| -32.48% | 1.17B | |
| +12.29% | 988M | |
| -37.86% | 884M |
- Stock Market
- Equities
- DEAR Stock
- Financials Duearity AB